Mukesh K. Nyati

5.2k citations

51 papers · 2.2k indexed · h-index 26

Oncology top 5%
- Cancer-related Molecular Pathways 9
- HER2/EGFR in Cancer Research 7
- Peptidase Inhibition and Analysis 4
Cancer Research top 5%
Molecular Biology top 5%
- Ubiquitin and proteasome pathways 8
- Heat shock proteins research 8
- Protein Degradation and Inhibitors 5
Pulmonary and Respiratory Medicine top 5%
- Lung Cancer Treatments and Mutations 12
Otorhinolaryngology top 5%
- Head and Neck Cancer Studies 5

Co-authors: Theodore S. Lawrence Sooryanarayana Varambally Felix Y. Feng Arul M. Chinnaiyan Meredith A. Morgan Dipankar Ray Alnawaz Rehemtulla Aarif Ahsan
Cited by: Oncology Cancer Research Molecular Biology
Journals: Science (1 paper)Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (2 papers)
Partner nations: United States China India

In The Last Decade

Mukesh K. Nyati

50 papers receiving 2.2k citations

Peers

Countries citing papers authored by Mukesh K. Nyati

Since Specialization

Citations

This map shows the geographic impact of Mukesh K. Nyati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mukesh K. Nyati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mukesh K. Nyati more than expected).

Fields of papers citing papers by Mukesh K. Nyati

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mukesh K. Nyati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mukesh K. Nyati. The network helps show where Mukesh K. Nyati may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mukesh K. Nyati, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mukesh K. Nyati Line = papers co-authored together Mukesh K. Nyati links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Phosphorylation of TRIP13 at Y56 induces radiation resistance but sensitizes head and neck cancer to cetuximab Molecular Therapy ·Rajat Banerjee,Min Liu,Emily L. Bellile,Ligia B. Schmitd,Mitsuo Goto,Marsha-Kay Hutchinson,Priyanka Singh,Shuang Zhang,Dilna P.V. Damodaran,Mukesh K. Nyati,Matthew E. Spector,Brent B. Ward,Gregory T. Wolf,Keith Casper,Michelle Mierzwa,Nisha J. D’Silva	2021	17
2	Low-Dose Hsp90 Inhibitor Selectively Radiosensitizes HNSCC and Pancreatic Xenografts Clinical Cancer Research ·Ranjit K. Mehta,Sanjima Pal,Koushik Kondapi,Merna Sitto,Cuyler Dewar,Theresa P. Devasia,Matthew J. Schipper,Dafydd G. Thomas,Venkatesha Basrur,Manjunath P. Pai,Yoshihiro Morishima,Yoichi Osawa,William B. Pratt,Theodore S. Lawrence,Mukesh K. Nyati	2020	17
3	Chaperone Activity and Dimerization Properties of Hsp90α and Hsp90β in Glucocorticoid Receptor Activation by the Multiprotein Hsp90/Hsp70-Dependent Chaperone Machinery Molecular Pharmacology ·Yoshihiro Morishima,Ranjit K. Mehta,Miyako Yoshimura,Miranda Lau,Daniel R. Southworth,Theodore S. Lawrence,William B. Pratt,Mukesh K. Nyati,Yoichi Osawa	2018	16
4	KRAS Protein Stability Is Regulated through SMURF2: UBCH5 Complex-Mediated β-TrCP1 Degradation Neoplasia ·Shirish Shukla,Uday Sankar Allam,Aarif Ahsan,Guoan Chen,Pranathi M. Krishnamurthy,Katherine B. Marsh,Matthew Rumschlag,Sunita Shankar,Christopher E. Whitehead,Matthew J. Schipper,Venkatesha Basrur,Daniel R. Southworth,Arul M. Chinnaiyan,Alnawaz Rehemtulla,David G. Beer,Theodore S. Lawrence,Mukesh K. Nyati,Dipankar Ray	2014	78
5	Tristetraprolin Mediates Radiation-Induced TNF-α Production in Lung Macrophages PLoS ONE ·Dipankar Ray,Shirish Shukla,Uday Sankar Allam,Abigail Helman,Susmita G. Ramanand,Linda Tran,M. Bassetti,Pranathi M. Krishnamurthy,Matthew Rumschlag,Michelle T. Paulsen,Lei Sun,Thomas P. Shanley,Mats Ljungman,Mukesh K. Nyati,Ming Zhang,Theodore S. Lawrence	2013	12
6	Molecular Imaging of TGFβ-Induced Smad2/3 Phosphorylation Reveals a Role for Receptor Tyrosine Kinases in Modulating TGFβ Signaling Clinical Cancer Research ·Shyam Nyati,Katrina Schinske,Dipankar Ray,Mukesh K. Nyati,Brian D. Ross,Alnawaz Rehemtulla	2011	37
7	Early Tumor Progression Associated with Enhanced EGFR Signaling with Bortezomib, Cetuximab, and Radiotherapy for Head and Neck Cancer Clinical Cancer Research ·Athanassios Argiris,Austin G. Duffy,Shivaani Kummar,Nicole L. Simone,Yoshio Arai,Seungwon W. Kim,Susan F. Rudy,Vishnu R. Kannabiran,Xinping Yang,Minyoung Jang,Zhong Chen,Nanette Suksta,Theresa Cooley-Zgela,Susmita G. Ramanand,Aarif Ahsan,Mukesh K. Nyati,James R. Wright,Carter Van Waes	2011	44
8	Molecular imaging of epidermal growth factor receptor kinase activity Analytical Biochemistry ·Amjad Khan,Joseph N. Contessa,Mukesh K. Nyati,Brian D. Ross,Alnawaz Rehemtulla	2011	11
9	Molecular Imaging of Akt Enables Early Prediction of Response to Molecular Targeted Therapy Translational Oncology ·Mahaveer S. Bhojani,Mukesh K. Nyati,Lili Zhao,Daniel P. Normolle,Brian D. Ross,Theodore S. Lawrence,Alnawaz Rehemtulla	2011	6
10	Role of Epidermal Growth Factor Receptor Degradation in Cisplatin-Induced Cytotoxicity in Head and Neck Cancer Cancer Research ·Aarif Ahsan,Susan M. Hiniker,Susmita G. Ramanand,Shyam Nyati,Ashok N. Hegde,Abigail Helman,Radhika Menawat,Mahaveer S. Bhojani,Theodore S. Lawrence,Mukesh K. Nyati	2010	57
11	Role of Cell Cycle in Epidermal Growth Factor Receptor Inhibitor-Mediated Radiosensitization Cancer Research ·Aarif Ahsan,Susan M. Hiniker,Mary A. Davis,Theodore S. Lawrence,Mukesh K. Nyati	2009	45
12	Effect of Epidermal Growth Factor Receptor Inhibitor Class in the Treatment of Head and Neck Cancer with Concurrent Radiochemotherapy In vivo Clinical Cancer Research ·Felix Y. Feng,Carlos López,Daniel P. Normolle,Sooryanarayana Varambally,Xiaoxin Li,Patrick Chun,Mary A. Davis,Theodore S. Lawrence,Mukesh K. Nyati	2007	41
13	Phenylbutyrate Sensitizes Human Glioblastoma Cells Lacking Wild-Type P53 Function to Ionizing Radiation International Journal of Radiation OncologyBiologyPhysics ·Carlos López,Felix Y. Feng,Joseph M. Herman,Mukesh K. Nyati,Theodore S. Lawrence,Mats Ljungman	2007	33
14	Ataxia Telangiectasia Mutated Down-regulates Phospho-Extracellular Signal-Regulated Kinase 1/2 via Activation of MKP-1 in Response to Radiation Cancer Research ·Mukesh K. Nyati,Felix Y. Feng,Divya Maheshwari,Sooryanarayana Varambally,Steven P. Zielske,Aarif Ahsan,Patrick Chun,Vinay A. Arora,Mary A. Davis,Mira Jung,Mats Ljungman,Christine E. Canman,Arul M. Chinnaiyan,Theodore S. Lawrence	2006	25
15	Synergistic Effects of Gemcitabine and Gefitinib in the Treatment of Head and Neck Carcinoma Cancer Research ·Patrick Chun,Felix Y. Feng,Ashley M. Scheurer,Mary A. Davis,Theodore S. Lawrence,Mukesh K. Nyati	2006	67
16	Role of epidermal growth factor receptor degradation in gemcitabine-mediated cytotoxicity Oncogene ·Felix Y. Feng,Sooryanarayana Varambally,Scott A. Tomlins,Patrick Chun,Carlos López,X. Li,Mary A. Davis,Arul M. Chinnaiyan,Theodore S. Lawrence,Mukesh K. Nyati	2006	64
17	Integration of EGFR inhibitors with radiochemotherapy Nature reviews. Cancer ·Mukesh K. Nyati,Meredith A. Morgan,Felix Y. Feng,Theodore S. Lawrence	2006	231
18	Radiosensitization by Pan ErbB Inhibitor CI-1033 *in Vitro* and *in Vivo* Clinical Cancer Research ·Mukesh K. Nyati,Divya Maheshwari,Sheela Hanasoge,Arun Sreekumar,Susan D. Rynkiewicz,Arul M. Chinnaiyan,Wilbur R. Leopold,Stephen P. Ethier,Theodore S. Lawrence	2004	67
19	Modulation of extracellular receptor kinase (ERK) by radiation Cancer Research ·Mukesh K. Nyati,Divya Maheshwari,Vinay A. Arora,Mary A. Davis,Theodore S. Lawrence	2004	1
20	Evaluation of certain ureas and nitrosoureas of 2,3-dihydro-1,4-benzothiazines against Sarcoma-180 solid tumors in vivo Anti-Cancer Drugs ·Mukesh K. Nyati,Chandra Mohan Rajoria,Radha Raman Gupta,P.K. Dev	1995	2

About Mukesh K. Nyati

Mukesh K. Nyati is a scholar working on Otorhinolaryngology, Oncology and Molecular Biology, having authored 51 papers that have together received 2.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (12 papers), Cancer-related Molecular Pathways (9 papers), Ubiquitin and proteasome pathways (8 papers), Heat shock proteins research (8 papers), HER2/EGFR in Cancer Research (7 papers), Protein Degradation and Inhibitors (5 papers), Head and Neck Cancer Studies (5 papers) and Peptidase Inhibition and Analysis (4 papers). The work is most often cited by research in Oncology (768 citations), Cancer Research (346 citations) and Molecular Biology (1.5k citations). Mukesh K. Nyati has collaborated with scholars based in United States, China and India. Frequent co-authors include Theodore S. Lawrence, Sooryanarayana Varambally, Felix Y. Feng, Arul M. Chinnaiyan, Meredith A. Morgan, Dipankar Ray, Alnawaz Rehemtulla, Aarif Ahsan, Arun Sreekumar and Ram S. Mani. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact